Abstracts - faqs.org

Abstracts

Seniors

Search abstracts:
Abstracts » Seniors

Resistance training in the early postoperative phase reduces hospitalization and leads to muscle hypertrophy in elderly hip surgery patients- A controlled, randomized study

Article Abstract:

A study to better understand how immobilization and surgery affect muscle size and function in the elderly and to identify effective training regimes is presented. An investigation of whether elderly patients who had undergone the hip-replacement surgery could benefit from additional training in the early postoperative phase and more specifically what training modality would be most effective is made.

Author: Magnusson, S. Peter, Aagaard, Per, Kjaer, Michael, Suetta, Charlotte, Rosted, Anna, Jakobsen, Ane K., Larsen, Lone H., Duus, Benn
Publisher: Blackwell Publishers Ltd.
Publication Name: Journal of the American Geriatrics Society
Subject: Seniors
ISSN: 0002-8614
Year: 2004
Muscle diseases, Muscular diseases, Hip replacement arthroplasty

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Efficacy and safety of Rofecoxib 12.5 mg versus Nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial

Article Abstract:

The structural development of osteoarthritis (OA) is generally gradual over a lifespan, with the disorder affecting up to 80 percent of the population of the United States by age 65 and virtually everyone aged 75 and older. An evaluation of the usage of starting doses of rofecoxib and nabumetone in patients with OA of the knee is illustrated.

Author: Dixon, Mary E., Polis, Adam B., Geba, Gregory P., Kivitz, Alan J., Greenwald, Maria W., Cohen, Stanley B., Najarian Daryl K., Moidel, Robert A., Green, Jerry A., Baraf, Herbert S.B., Petruschke, Richard A., Matsumoto, Alan K.
Publisher: Blackwell Publishers Ltd.
Publication Name: Journal of the American Geriatrics Society
Subject: Seniors
ISSN: 0002-8614
Year: 2004
Development and progression, Osteoarthritis, Dosage and administration, Rofecoxib, Nabumetone

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial

Article Abstract:

A trial to testify the hypothesis that a micronutrient supplement can improve seroconversion after influenza immunization in older institutionalized people is given. The results propose that micronutrient supplement had no beneficial effect on antibody response to influenza vaccine in older people.

Author: Taylor, Stephen, Allsup, Stephen J.; Shenkin, Alan, Gosney, Margot A., Hammond, Margaret; Zambon, Maria C.
Publisher: Blackwell Publishers Ltd.
Publication Name: Journal of the American Geriatrics Society
Subject: Seniors
ISSN: 0002-8614
Year: 2004
Prevention, Influenza, Immunization

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Aged, Elderly, Research, United States
Similar abstracts:
  • Abstracts: A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients
  • Abstracts: Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial
  • Abstracts: The healthcare costs of sarcopenia in the United States. Prevalence and correlates of functional disability in multiethnic elderly Singaporeans
  • Abstracts: Restraint reduction and legal risk management. Medical mistakes and older patients: admitting errors and improving care
  • Abstracts: Elderly Hispanic migration in the United States. Black retirement migration in the United States. Regional retirement migration: the case of Cape Cod
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.